Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
242.66
-8.19 (-3.26%)
Feb 12, 2026, 2:43 PM EST - Market open
Insulet Employees
Insulet had 3,900 employees as of December 31, 2024. The number of employees increased by 900 or 30.00% compared to the previous year.
Employees
3,900
Change (1Y)
900
Growth (1Y)
30.00%
Revenue / Employee
$646,615
Profits / Employee
$63,128
Market Cap
17.07B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 3,900 | 900 | 30.00% |
| Dec 31, 2023 | 3,000 | 400 | 15.38% |
| Dec 31, 2022 | 2,600 | 300 | 13.04% |
| Dec 31, 2021 | 2,300 | 400 | 21.05% |
| Dec 31, 2020 | 1,900 | 550 | 40.74% |
| Dec 31, 2019 | 1,350 | 181 | 15.48% |
| Dec 31, 2018 | 1,169 | 312 | 36.41% |
| Dec 31, 2017 | 857 | 217 | 33.91% |
| Dec 31, 2016 | 640 | -7 | -1.08% |
| Dec 31, 2015 | 647 | 128 | 24.66% |
| Dec 31, 2014 | 519 | 41 | 8.58% |
| Dec 31, 2013 | 478 | -60 | -11.15% |
| Dec 31, 2012 | 538 | -38 | -6.60% |
| Dec 31, 2011 | 576 | 266 | 85.81% |
| Dec 31, 2010 | 310 | 34 | 12.32% |
| Dec 31, 2009 | 276 | -18 | -6.12% |
| Dec 31, 2008 | 294 | 47 | 19.03% |
| Dec 31, 2007 | 247 | -47 | -15.99% |
| Dec 31, 2006 | 294 | 47 | 19.03% |
| Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Koninklijke Philips | 67,823 |
| GE HealthCare Technologies | 54,000 |
| Smith & Nephew | 18,060 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
| DexCom | 10,300 |
| Bio-Rad Laboratories | 7,700 |
| Bio-Rad Laboratories | 7,700 |
PODD News
- 7 days ago - Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care - Business Wire
- 24 days ago - Is PODD A Better Bet Than ISRG Stock? - Forbes
- 4 weeks ago - Insulet Corporation (PODD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 - Business Wire
- 5 weeks ago - Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health - Business Wire
- 2 months ago - Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future - Business Wire
- 2 months ago - Eight stock picks to play one of the healthiest corners of the market - Market Watch